About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Terumo Aortic Global Endovascular Registry | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT04246463

Terumo Aortic Global Endovascular Registry

Multi-arm, multi-center, open label, prospective observational registry designed to obtain safety and performance data on the use of CE marked and custom Terumo Aortic endovascular grafts.

Lead sponsor: Vascutek Ltd.•17 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Michelle Durnan

CONTACT

+44 141 343 0195 [email protected]

Sammy Jassal

CONTACT

+44 141 343 0195 [email protected]

Sponsors

Lead Sponsor

Vascutek Ltd.

Collaborators

Bolton Medical

Post Market registry collecting real world, post-approval safety, performance, patient reported outcomes and health economic data on patients treated with Terumo Aortic endovascular stent-grafts in standard clinical practice.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Minimum age as per local regulations
•Indication for aortic endovascular repair with an approved or CE marked by a Regulatory body or custom-made Terumo Aortic Endovascular graft
•Ability to provide informed consent
•o Emergent cases (typically younger patients with traumatic injuries) are not excluded if there is IRB/EC agreement to allow consent after intervention (i.e. consent to study participation, not to treatment) or use of a Legally Authorized Representative (LAR).
•Willingness to comply with the registry protocol
•Willingness to adhere to follow-up visits Note: Patients currently enrolled and actively participating within the TREO registry (IP-0020-16) can have their data migrated from TREO to the TiGER registry where local EC approval has been obtained and the patient has been reconsented to TiGER for longer follow-up.

Exclusion Criteria

•Patient is unable or unwilling to comply with the study follow-up regime. Patient is contraindicated per the IFU, or has any other medical, social or psychological problems that in the opinion of the investigator preclude them from receiving treatment as well as the procedures and evaluations pre and post procedure.

Related studies

RECRUITINGPhase 1

Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)

NCT07223983 · Alcohol Use Disorder, Weight Loss, and more

Can Pre-operative Lean Mass Predict Weight Loss After Roux-en-Y Gastric Bypass?

NCT07565051 · Morbid Obesity Requiring Bariatric Surgery

Effect of Titrated Administration of Ciprofol on Perioperative Hypotension in Elderly Patients Undergoing Laparoscopic Abdominal Surgery: A Randomized Controlled Trial

NCT07328958 · Hypotension During Surgery

RECRUITINGPhase 4

LANdiolol to Avoid TAchycardia in Patients at Risk for Cardiovascular Events Undergoing Major Non-cardiac Surgery

NCT07168421 · Perioperative Myocardial Injury, Autonomic Dysfunction, and more

Feasibility of a Multimodal Virtual Reality Intervention to Reduce Preoperative Anxiety in Cancer Surgery Patients

NCT07366515 · Oncologic Surgery

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 13, 2026Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment1,000

Start dateDec 2019

Last updatedMar 13, 2026

Condition

Abdominal Aortic Aneurysm Thoracic Aortic Aneurysm Surgery

Locations shown

Long Beach Memorial Medical Center

Long Beach, California

University of Colorado Anschutz Medical Campus

Aurora, Colorado

UC Health Memorial Hospital Center

Colorado Springs, Colorado

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 13, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions